The medical equipment market in Spain

The French medical device market is estimated at between 25 and 35 billion euros The global medical devices market, valued at over$500 billion, is expected to grow at an average annual rate of 5.5%. Dominated by the United States with a 43% market share, the market has seen an increase in demand for a variety of equipment due to an aging population and a rise in chronic diseases. The French medical equipment market grew by 10% between 2017 and 2021, propelled by exports, which rose by 4.3% in 2021. Dynamics of the French medical equipment market The sector encompasses a wide range of products, from hospital equipment and diagnostic devices to cutting-edge e-health solutions. France occupies an important place in the global landscape, with a market estimated at between 25 and 35 billion euros, representing around 5 to 6.5% of the world market. The market covers devices for individual use, non-active implants, in vitro diagnostics and online health monitoring systems. The proportion of p

A medical device is defined in Regulation 2017/745/EU as "an instrument, apparatus, equipment or software intended by its manufacturer to be used for the diagnosis, prevention, control, treatment of disease, injury or other purposes".

The global market for medical biology laboratories has been experiencing significant growth, which was further accelerated by the health crisis in 2020 due to the COVID-19 pandemic. In Spain, this market saw an increase of 33% in 2021, with the market size estimated at 4.8 billion euros. The pandemic resulted in an unprecedented demand for COVID tests, contributing to a substantial portion of sales for many laboratories, such as Unilabs reporting 40% of sales from COVID tests in 2020. The market in Spain, however, remains highly fragmented with the top two companies accounting for just 8.6% of the market share. COVID-19 tests were found to be expensive in Spain, with PCRs costing between 75 and 150 euros without a prescription. Despite this upsurge, the market is expected to return to slightly above pre-crisis levels in 2022. The demand for medical laboratory services is driven by the need for routine care, with clinical biochemistry and hematology comprising 93% of total analyses. Env